Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IMTX | AVLN |
|---|---|---|
| Price | $7.45 | $25.53 |
| Change today | ▼ 0.67% | ▲ 0.39% |
| Market cap | $1.11B | $1.13B |
| Return, 3 months | -25.2% | -11.7% |
| Return, year to date | -29.0% | – |
| Return, 1 year | -28.2% | – |
| P/E (TTM) | -4.2 | -11.0 |
| P/B | 2.5 | 2.8 |
| P/E percentile vs own 5y | 73rd | 95th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +93.0% | – |
| Net profit growth (YoY) | +11.2% | -43.3% |
| Gross margin | – | – |
| Operating margin | -543.8% | – |
| Net margin | -495.3% | – |
| Return on equity | -47.8% | -25.9% |
| Analyst target vs. price | +137.6% | +120.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 30 | 31 |
| 30-day volatility | 43.0% | 55.6% |
| Max drawdown, 1 year | -37.2% | -35.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
